A study published in this month’s issue of the British Journal of Pharmacology has found that cannabis may treat stress-related illnesses “with a neuroinflammatory component”, such as depression.
For the study researchers conducted various experiments with animal models (in this instance, rats) and found that activating certain cannabinoid receptors was successful in reversing the inflammatory response caused by stress.
Researchers conclude that; “These results suggest that pharmacological manipulation of CB2 receptor is a potential therapeutic strategy for the treatment of stress-related pathologies with a neuroinflammatory component, such as depression.
Although the study used synthetic cannabinoids, its results imply that cannabis could be used as a treatment for these conditions, given that cannabis naturally activates and regulates the body’s cannabinoid receptors.
The study was conducted by researchers at Complutense University in Spain.